Research News
Ovarian Cancer Canada funds research into prevention, improved treatments, and ultimately a cure. Science continues to uncover new knowledge that impacts treatment and survival. Here’s how.
In the news recently, scientists at Lawson Health Research Institute have identified a new target for ovarian cancer therapies. New data shows that LKB1, a molecule previously thought to slow the growth of cancer, can also promote tumour survival.
In the news recently, research out of the Department of Biomedical Sciences at the University of Guelph shows potential to shrink ovarian tumours while improving drug delivery.
Ovarian Cancer Canada announces this year’s recipient of the Karen Campbell Award for Research Excellence. Congratulations to Dr. Barbara Vanderhyden.
In the past six years, scientific discoveries have fundamentally changed our understanding of ovarian cancer and propelled researchers and clinicians in new directions in their quest to overcome Canada’s most fatal women’s cancer.
Trainee Day: educational and enriching. By Genevieve Lennox
and
West coast survivors receive ovarian cancer research update. By Rochelle van Halm
The American Society of Clinical Oncology (ASCO)’s annual meeting took place from May 30-June 3, 2014. Here are the ovarian cancer highlights.
From May 25-27, 2014, the 7th Canadian Conference on Ovarian Cancer Research (CCOCR) was held in Victoria, British Columbia. Here are the highlights.
A recent study estimated reduction in risk of ovarian, fallopian and peritoneal cancer in women in a study group with BRCA 1 or BRCA 2 mutation after oophorectomy, by age of oophorectomy; to estimate the impact of prophylactic oophorectomy on all-cause mortality and to estimate 5 year survival associated with clinically detected ovarian, occult and peritoneal cancers.
This is the final in a series of articles about ovarian cancer research in Canada. Our thanks to Dr. Barbara Vanderhyden (see bio at end) for preparing this series of lay articles for our readers.
This is another in a series of articles about advances in the field of ovarian cancer research. Our thanks to Dr. Barbara Vanderhyden (see bio at end) for preparing this series of lay articles for our readers.